Five participants received SGT-212 in the Phase 1b FALCON trial; initial data are expected in Q1 2027. FDA granted three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results